Testosterone cream vs pellets comes down to daily topical delivery versus a subcutaneous implant that releases testosterone over several months. ANDROGEL is applied to the skin and carries a boxed warning about secondary exposure to children.1 TESTOPEL is implanted under the skin, and the amount placed cannot be revised during the release interval.2 No cited study compares these routes head to head, so your physician must weigh delivery pattern, home contact, procedure preference, symptoms, and repeat labs.
The Two Labeled Testosterone Products
ANDROGEL is a testosterone gel used for transdermal delivery. Although people commonly search for testosterone cream, the labeled product examined here is a gel. It is applied daily, which allows your prescriber to review future applications when your symptoms or lab results call for a change.1
TESTOPEL consists of testosterone pellets implanted subcutaneously. The pellets release testosterone over an extended period after placement, removing the daily application routine. The amount already implanted remains fixed during that interval.2
Both products are used for testosterone replacement in people with an established testosterone deficiency. Your prescriber should confirm the diagnosis and review your exact prescription before comparing routes.
How Testosterone Cream vs Pellets Differ
Cream or gel gives your physician more opportunities to revise treatment because you apply it each day. Pellets provide a longer release period, but changes generally wait until the next implantation.
| Route | Formulation basis (from the label) | Unique labeled risk | Concentration pattern over time | Whether the dose can be adjusted mid-interval |
|---|---|---|---|---|
| Testosterone cream or gel | ANDROGEL is a testosterone gel applied to the skin for transdermal absorption.1 | The boxed warning addresses secondary exposure. Virilization has been reported in children exposed to testosterone gel through contact with treated skin.1 | Daily application provides repeated transdermal delivery. Future applications can be stopped or reviewed by your prescriber. | Yes. Your prescriber can revise future applications after reviewing symptoms, labs, and tolerability. |
| Testosterone pellets | TESTOPEL contains testosterone pellets implanted subcutaneously.2 | Implantation requires a procedure and commits the placed amount for the release interval. The supplied label information does not establish a topical secondary-exposure warning.2 | A review found that studied pellet regimens raised total testosterone into the therapeutic range at about one month and sustained it for four to six months.3 | No. The amount already implanted cannot be changed before the next implantation. |
The routes also place responsibility in different parts of your routine. Gel requires daily use and precautions around close skin contact. Pellets require an office procedure and acceptance of a treatment amount that remains in place for months.
Neither pattern establishes better effectiveness for every person. Your physician needs your lab trend and symptoms to determine whether the selected route is producing an appropriate response.
Secondary Exposure With Testosterone Gel
Secondary exposure is the main household issue that separates topical testosterone from pellets. The ANDROGEL label carries the following boxed warning:
> “WARNING: SECONDARY EXPOSURE TO TESTOSTERONE. Virilization has been reported in children who were secondarily exposed to testosterone gel... Children should avoid contact with unwashed or unclothed application sites in men using testosterone gel... Healthcare providers should advise patients to strictly adhere to recommended instructions for use.”1
This warning concerns testosterone transferred to another person through contact with a treated application site. It does not establish that gel causes more harm to the person receiving treatment than pellets.
Your living arrangements belong in the prescribing conversation. If you have young children or close contacts who could touch treated skin, tell your physician before choosing a topical route.
The Testosterone Pellet Release Pattern
Testosterone pellets follow a multi-month concentration curve that starts with the amount implanted. A pharmacotherapy review reported that implantation of six to ten-or-more pellets, representing 450 mg to 750 mg or more in the studies reviewed, increased total testosterone into the therapeutic range at about one month. Therapeutic levels were sustained for four to six months.3
Those figures describe published study regimens. They are not a personal dosing recommendation.
A separate cohort study found that testosterone and free-testosterone peaks were lower with six to nine pellets than with 10 to 12 pellets. Among men receiving 10 to 12 pellets, those with a body mass index of 25 kg/m² or higher had lower peaks and slower decay than men below that threshold. Both body mass index groups reached 300 ng/dL at about 100 days.4
The cohort did not identify one best pellet count. It showed that the number of pellets and body composition affect the concentration pattern.4 Your physician must account for that variability before implantation because the placed amount cannot be revised afterward.
Factors in the Prescribing Decision
A prescriber weighs how each delivery route fits your life and how much adjustment flexibility your treatment may require.
- Daily routine: Topical gel requires an application each day. Your physician will consider whether that routine is realistic for you before prescribing it.
- Household contact: The gel label requires precautions to prevent children from contacting unwashed or unclothed application sites.1 Your home environment can therefore change whether topical treatment is a reasonable fit.
- Procedure preference: Pellets require subcutaneous implantation.2 If you want to avoid a procedure, tell your physician before a pellet treatment plan is built.
- Adjustment flexibility: Your prescriber can review future gel applications after new symptoms or lab results. A pellet amount remains in place during its release interval.
- Lab response: Both routes require periodic laboratory testing and clinical review. One testosterone result gives your physician a data point, while repeat results show the direction and stability of your response.
Topical gel may be a poor fit when household exposure precautions cannot be followed consistently. A route without treated skin may be easier to manage in that situation, but your physician still needs to evaluate the complete treatment profile.
Pellets may be a poor fit when you want near-term prescribing flexibility or prefer to avoid an implantation procedure. Your physician can discuss a route with more frequent opportunities for review.
Related Testosterone Route Decisions
Questions about injections require separate evidence. The direct testosterone injections vs cream comparison covers the first two FAQ topics in more depth, while testosterone pellets vs injections addresses the other route pairing.
Questions about a specific injectable ester belong in the testosterone cypionate overview. Medication, laboratory, and clinical expenses are covered in the TRT cost guide.
These comparisons help you separate route-specific concerns before your physician reviews your diagnosis and treatment goals.
The Opt Take on Testosterone Cream vs Pellets
At Opt Health, the route is one part of a broader treatment pattern. We start with 55+ biomarkers and a one-on-one physician review. Labs and the physician consultation repeat every three to four months, allowing the plan to change based on your measured response.
A single testosterone result cannot show how your concentration changes across a daily or multi-month delivery cycle. Your physician needs the trend, your symptoms, current medications, household contact concerns, and treatment preferences.
Bring the exact product name and your recent lab results to your physician when discussing testosterone cream vs pellets.
Get started: Begin with Opt Health, where a physician reads your labs, builds your plan, and adjusts it over the loop.
Frequently Asked Questions
The available evidence here cannot determine whether testosterone cream or injections is better. The cited sources examine topical gel and pellets, and none evaluates injections.
Cream or gel provides daily transdermal delivery and carries a secondary-exposure warning.1 The route named in your question has different formulation and monitoring considerations, which are covered in the dedicated injections-versus-cream comparison linked above. Your physician should compare those routes using your diagnosis, symptoms, and lab response.
The four cited sources do not provide a direct effectiveness comparison between testosterone cream and injection. They also do not support a universal ranking across testosterone routes.
For cream or gel, treatment response depends on the testosterone concentration achieved and how your symptoms change. The sources used here establish the topical delivery pattern and secondary-exposure warning.1 Your physician needs route-specific evidence and repeat labs before deciding whether cream is producing an appropriate response for you.
The main pellet tradeoffs are the implantation procedure, a multi-month release curve, and limited adjustment after placement. TESTOPEL is implanted subcutaneously, so the amount already placed cannot be revised during that interval.2
Pellet peaks also vary with the number implanted and body mass index.4 Your physician must choose the treatment plan before placement and then interpret your symptoms and follow-up labs within that fixed release period.
The cited TESTOPEL label does not establish a universal maximum number of years for treatment. It gives a replacement-therapy dosing guideline of 150 mg to 450 mg subcutaneously every three to six months.2 That interval is a regulatory description and does not set your personal treatment schedule.
Continued treatment depends on your diagnosis, response, tolerability, and ongoing clinical review. Bring your symptoms, lab trend, household contact concerns, and procedure preference to your physician when reviewing testosterone cream vs pellets.
References
- Ascend Therapeutics U.S., LLC. ANDROGEL (testosterone) gel. DailyMed. Accessed September 22, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f4e8d29b-8707-4d47-e053-2a95a90aecee
- Auxilium Pharmaceuticals; Endo Pharmaceuticals. TESTOPEL (testosterone) pellet: full prescribing information. DailyMed. Accessed September 22, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a1741a0b-3d4c-42dc-880d-a06e96cce9ef
- Kresch E, Patel M, Lima TFN, Ramasamy R. An update on the available and emerging pharmacotherapy for adults with testosterone deficiency available in the USA. Expert Opin Pharmacother. 2021;22(13):1761-1771. https://pubmed.ncbi.nlm.nih.gov/33866902/
- Pastuszak AW, Mittakanti H, Liu JS, Gomez L, Lipshultz LI, Khera M. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. J Androl. 2012;33(5):927-937. https://pubmed.ncbi.nlm.nih.gov/22403285/
This content is for informational purposes and does not replace evaluation, diagnosis, or treatment by a qualified medical professional.
This article is part of our guide to testosterone. See how physician-managed TRT works at Opt Health.
Start Today
Your health, your terms. Discover how personalized care can transform not just the way you feel, but how you live.